Starsource Multitrad
Ticker > Company >

Starsource Multitrad share price

Starsource Multitrade Ltd.

BSE: 506365 SECTOR: Pharmaceuticals & Drugs  7.34 K   16   0

125.35
-6.65 (-5.04%)
BSE: Today, 02:23 PM

Price Summary

Today's High

₹ 132

Today's Low

₹ 125.3

52 Week High

₹ 154

52 Week Low

₹ 59.58

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 18.8 Cr.

Enterprise Value

₹ 12.7 Cr.

No. of Shares

0.15 Cr.

P/E

0

P/B

14.03

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.93

CASH

₹ 6.11 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

27.89 %

EPS (TTM)

₹  -78.04

Sales Growth

0%

ROE

9.84 %

ROCE

13.49%

Profit Growth

2437.67 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 YearNA
3 YearNA
5 YearNA

Profit Growth

1 Year2437.67%
3 Year68.69%
5 Year42.22%

ROE%

1 Year9.84%
3 Year5.07%
5 Year4.29%

ROCE %

1 Year13.49%
3 Year5.83%
5 Year5.01%

Debt/Equity

0

Price to Cash Flow

25.98

Interest Cover Ratio

802.3506

CFO/PAT (5 Yr. Avg.)

1.67238039401531

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 27.89 0.00
Mar 2025 27.89 0.00
Dec 2024 27.89 0.00
Sep 2024 27.89 0.00
Jun 2024 27.89 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Company has a healthy liquidity position with current ratio of 35.0964.

 Limitations

  • Company has a poor ROE of 5.07076405191973% over the past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 0 0 0 0 0
Total Expenditure 0.05 0.02 0.02 0.02 11.83
Operating Profit -0.05 -0.02 -0.02 -0.02 -11.83
Other Income 0.3 0.63 -0.15 -0.16 0.02
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.25 0.61 -0.17 -0.18 -11.81
Tax 0 0 0 0.16 0
Profit After Tax 0.25 0.61 -0.17 -0.34 -11.81
Adjusted EPS (Rs) 1.65 4.07 -1.16 -2.25 -78.7

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 0 0 0 0
Total Expenditure 0.48 0.33 0.5 0.61 0.18
Operating Profit -0.48 -0.33 -0.5 -0.61 -0.18
Other Income 1 0.67 0.88 0.71 1.84
Interest 0 0 0 0.01 0
Depreciation 0.02 0.02 0.02 0.01 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.49 0.31 0.36 0.07 1.64
Tax 0.08 0.06 -0.2 0.03 0.44
Net Profit 0.42 0.25 0.56 0.05 1.2
Adjusted EPS (Rs.) 2.77 1.67 3.73 0.32 8

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 1.5 1.5 1.5 1.5 1.5
Total Reserves 9.24 9.49 10.05 10.1 11.3
Borrowings 0 0 0 0 0
Other N/C liabilities 0 0 -0.26 -0.24 0.03
Current liabilities 0.22 0.06 0.11 0.02 0.18
Total Liabilities 10.97 11.05 11.4 11.38 13.02
Assets
Net Block 0.07 0.05 0.04 0.03 0.02
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.02 0.04 2.94 3.03 4.4
Loans & Advances 1.96 0 2.12 2.2 2.35
Other N/C Assets 0 0 0 0 0
Current Assets 8.91 10.96 6.3 6.13 6.25
Total Assets 10.97 11.05 11.4 11.38 13.02
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.49 0.31 0.36 0.07 1.64
Adjustment -0.97 -0.51 -0.65 -0.7 -0.84
Changes in Assets & Liabilities 5.39 -0.13 0.02 -0.05 0.09
Tax Paid -0.08 -0.09 -0.06 -0.01 -0.17
Operating Cash Flow 4.83 -0.41 -0.33 -0.68 0.72
Investing Cash Flow 1.01 -0.19 0.97 0.63 -0.52
Financing Cash Flow 0 1.96 -2.12 -0.08 -0.15
Net Cash Flow 5.84 1.36 -1.49 -0.13 0.05

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 27.89 27.89 27.89 27.89 27.89
citric india ltd 24.63 24.63 24.63 24.63 24.63
shanta somani 3.25 3.25 3.25 3.25 3.25
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 72.11 72.11 72.11 72.11 72.11
kshemtech media private l... - - - - 3.63
ravindra somani - - - - 3.16
sudhanshu kanda - - - - 1.28
sudhir harilal kale - - - - 2.33
llp - - - 0.13 -
ravindra somani 3.16 3.16 3.16 3.16 -
shree consultation and s... 3.63 3.63 3.63 3.63 -
sudhir harilal kale 2.33 2.33 2.33 2.33 -
mahendrabhai gulabdas pat... - 1.28 - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Chemo Pharma Laboratories informs about appointment of CS cum CO 12 Sep, 5:18 PM Chemo Pharma Labs - Quaterly Results 12 Aug, 7:09 PM Chemo Pharma Labs - Quaterly Results 12 Aug, 7:09 PM Chemo Pharma Laboratories informs about board meeting 28 Jul, 5:24 PM Chemo Pharma Laboratories informs about disclosure 15 Jul, 10:23 AM Chemo Pharma Laboratories informs about disclosure 15 Jul, 10:22 AM Chemo Pharma Laboratories informs about closure of trading window 31 Mar, 3:26 PM Chemo Pharma Labs - Quaterly Results 27 Jan, 5:03 PM Chemo Pharma Labs - Quaterly Results 27 Jan, 5:03 PM Chemo Pharma Labs - Quaterly Results 27 Jan, 5:03 PM Chemo Pharma Labs - Quaterly Results 29 Oct, 12:00 PM Chemo Pharma Laboratories informs about disclosure 8 Oct, 4:54 PM Chemo Pharma Labs - Quaterly Results 29 Jul, 5:34 PM Chemo Pharma Labs - Quaterly Results 29 Jul, 5:34 PM Chemo Pharma Labs - Quaterly Results 29 Jul, 5:34 PM Chemo Pharma Laboratories informs about compliance certificate 2 Jul, 4:20 PM Chemo Pharma Labs - Quaterly Results 27 May, 5:31 PM Chemo Pharma Labs - Quaterly Results 27 May, 5:31 PM Chemo Pharma Labs - Quaterly Results 27 May, 5:31 PM Chemo Pharma Laboratories informs about loss of share certificates 23 Apr, 4:59 PM Chemo Pharma Labs - Quaterly Results 29 Jan, 5:17 PM Chemo Pharma Labs - Quaterly Results 29 Jan, 5:17 PM Chemo Pharma Labs - Quaterly Results 29 Jan, 5:17 PM Chemo Pharma Labs - Quaterly Results 27 Oct, 5:19 PM Chemo Pharma Labs - Quaterly Results 27 Oct, 5:19 PM Chemo Pharma Labs - Quaterly Results 27 Oct, 5:19 PM Chemo Pharma Laboratories informs about board meeting 16 Oct, 4:51 PM Chemo Pharma Laboratories informs about declaration of non-applicability of disclosure 9 Oct, 5:06 PM Chemo Pharma Labs - Quaterly Results 27 Jul, 5:22 PM Chemo Pharma Labs - Quaterly Results 27 Jul, 5:22 PM Chemo Pharma Labs - Quaterly Results 27 Jul, 5:22 PM Chemo Pharma Labs - Quaterly Results 24 May, 5:46 PM Chemo Pharma Labs - Quaterly Results 24 May, 5:46 PM Chemo Pharma Laboratories informs about board meeting 15 May, 4:17 PM Chemo Pharma Laboratories informs about confirmation certificate 10 Apr, 5:01 PM Chemo Pharma Laboratories informs about newspaper advertisement 1 Feb, 5:22 PM Chemo Pharma Labs - Quaterly Results 31 Jan, 5:00 PM Chemo Pharma Labs - Quaterly Results 31 Jan, 5:00 PM Chemo Pharma Labs - Quaterly Results 31 Jan, 5:00 PM Chemo Pharma Laboratories informs about trading window closure 29 Dec, 2:19 PM Chemo Pharma Labs - Quaterly Results 20 Oct, 5:05 PM Chemo Pharma Labs - Quaterly Results 20 Oct, 5:05 PM Chemo Pharma Labs - Quaterly Results 28 Jul, 5:18 PM Chemo Pharma Labs - Quaterly Results 28 Jul, 5:18 PM Chemo Pharma Labs - Quaterly Results 28 Jul, 5:18 PM Chemo Pharma Laboratories informs about compliances certificate 4 Jul, 5:07 PM Chemo Pharma Laboratories informs about compliance certificate 7 Apr, 5:05 PM Chemo Pharma Laboratories informs about compliances certificate 4 Jan, 1:45 PM Chemo Pharma Laboratories informs about voting results and scrutinizer’s report of AGM 2 Sep, 3:46 PM Chemo Pharma Laboratories informs about appointment of additional director 29 Jan, 1:24 PM

Starsource Multitrad Stock Price Analysis and Quick Research Report. Is Starsource Multitrad an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Starsource Multitrad. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Starsource Multitrad has a PE ratio of -1.69144028703229 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Starsource Multitrad has ROA of 9.8412% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Starsource Multitrad has a Current ratio of 35.0964.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Starsource Multitrad has a ROE of 9.8375%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Starsource Multitrad has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Starsource Multitrad has reported revenue growth of 0% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Starsource Multitrad for the current financial year is 0%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Starsource Multitrad is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Starsource Multitrad is Rs -78.04. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Starsource Multitrad in Ticker for free. Also, one can get the intrinsic value of Starsource Multitrad by using Valuation Calculators, which are available with a Finology ONE subscription. 

Starsource Multitrad FAQs

Q1. What is Starsource Multitrad share price today?
Ans: The current share price of Starsource Multitrad is Rs 132.

Q2. What is the market capitalisation of Starsource Multitrad?
Ans: Starsource Multitrad has a market capitalisation of Rs 19.8 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Starsource Multitrad?
Ans: The PE ratio of Starsource Multitrad is -1.69144028703229 and the P/B ratio of Starsource Multitrad is 14.7761745379647, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Starsource Multitrad share?
Ans: The 52-week high share price of Starsource Multitrad is Rs 154, and the 52-week low share price of Starsource Multitrad is Rs 59.58.

Q5. Does Starsource Multitrad pay dividends?
Ans: Currently, Starsource Multitrad does not pay dividends. Dividend yield of Starsource Multitrad is around 0%.

Q6. What are the face value and book value of Starsource Multitrad shares?
Ans: The face value of Starsource Multitrad shares is Rs 10, while the book value per share of Starsource Multitrad is around Rs 8.9333. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Starsource Multitrad?
Ans: Starsource Multitrad has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Starsource Multitrad?
Ans: The ROE of Starsource Multitrad is 9.8375% and ROCE of Starsource Multitrad is 13.4862%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Starsource Multitrad a good buy for the long term?
Ans: The Starsource Multitrad long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Starsource Multitrad undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Starsource Multitrad appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Starsource Multitrad’s financials?
Ans: You can review Starsource Multitrad’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Starsource Multitrad
X